Your browser doesn't support javascript.
loading
Epidemiological Characteristics and Transmissibility of Human Immunodeficiency Virus in Nanning City, China, 2001-2020.
Lin, Qian; Deng, Bin; Rui, Jia; Guo, Song-Bai; Hu, Qingqing; Chen, Qiuping; Tang, Chi; Zhou, Lina; Zhao, Zeyu; Lin, Shengnan; Zhu, Yuanzhao; Yang, Meng; Wang, Yao; Xu, Jingwen; Liu, Xingchun; Yang, Tianlong; Li, Peihua; Li, Zhuoyang; Luo, Li; Liu, Weikang; Liu, Chan; Huang, Jiefeng; Yao, Min; Nong, Mengni; Nong, Liping; Wu, Jinglan; Luo, Na; Chen, Shihai; Frutos, Roger; Yang, Shixiong; Li, Qun; Cui, Jing-An; Chen, Tianmu.
Afiliación
  • Lin Q; Development Planning Office, Guangxi Medical University, Nanning, China.
  • Deng B; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Rui J; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Guo SB; Department of Mathematics and Data Science, School of Science, Beijing University of Civil Engineering and Architecture, Beijing, China.
  • Hu Q; Division of Public Health, School of Medicine, University of Utah, 201 Presidents Circle, Salt Lake, UT, United States.
  • Chen Q; Laboratory Intertryp CIRAD/IRD, Université de Montpellier, Montpellier, France.
  • Tang C; Department of Medical Insurance Office, Xiang'an Hospital of Xiamen University, Xiamen, China.
  • Zhou L; Division of Director's Office, Nanning Municipal Health Commission, Nanning, China.
  • Zhao Z; Department of Nephrology, The Second Hospital of Xiamen Medical College, Xiamen, China.
  • Lin S; Development Planning Office, Guangxi Medical University, Nanning, China.
  • Zhu Y; Laboratory Intertryp CIRAD/IRD, Université de Montpellier, Montpellier, France.
  • Yang M; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Wang Y; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Xu J; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Liu X; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Yang T; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Li P; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Li Z; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Luo L; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Liu W; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Liu C; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Huang J; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Yao M; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Nong M; Department of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
  • Nong L; Department of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
  • Wu J; Department of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
  • Luo N; Department of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
  • Chen S; Department of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
  • Frutos R; Department of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
  • Yang S; Division of Director's Office, Nanning Municipal Health Commission, Nanning, China.
  • Li Q; Department of Medical Insurance Office, Xiang'an Hospital of Xiamen University, Xiamen, China.
  • Cui JA; Department of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
  • Chen T; Department of Health Emergency, Chinese Center for Disease Control and Prevention, Beijing, China.
Front Public Health ; 9: 689575, 2021.
Article en En | MEDLINE | ID: mdl-35004557
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Public Health Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Public Health Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza